How can we navigate the looming threat of antimicrobial resistance (AMR) and shape the future of healthcare by 2049? Dr. Chandra Ghose, Chief Scientific Officer at Emily's Entourage, delves into the complexities of AMR, highlighting the critical need for global collaboration and innovative funding models. Drawing inspiration from the rapid response to the COVID pandemic, Dr. Ghose explores the economic challenges hindering antibiotic development with Health2049 co-host Jason Helgerson and envisions a future where technology, particularly artificial intelligence, plays a pivotal role in personalized antibiotic solutions. 

Connect with Health2049:

• Website: https://www.health2049.com
  
  

Find the complete Show Notes and Transcripts Here -> https://bit.ly/chandra-ghose

Timestamps:

• Dr. Chandra Ghose’s background. [03:40 ]
• A healthcare research from the UK. [10:04 ]
• A multi pronged medical solution. [13:33 ]
• Why don't we see more new antibiotics? [17:42 ]
• The development of life-saving antibiotics. [22:56 ]
• New approaches to treating infectious disease. [25:58 ]
• Human trials for new treatments? [30:33 ]
• Positive impact on our healthcare future. [34:05 ]

Episode Web Page: https://www.health2049.com/episodes